share_log

Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jan 16 13:00
Summary by Futu AI
Eli Lilly and Co, a major pharmaceutical company, is set to experience a significant transaction involving its common stock. LILLY ENDOWMENT INC, a key stockholder with a 10% stake, plans to sell 210,000 shares of Eli Lilly's common stock. The sale, with an aggregate market value of approximately $135 million, is scheduled for 01/16/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 225,000 shares of Eli Lilly, generating gross proceeds of nearly $142 million.
Eli Lilly and Co, a major pharmaceutical company, is set to experience a significant transaction involving its common stock. LILLY ENDOWMENT INC, a key stockholder with a 10% stake, plans to sell 210,000 shares of Eli Lilly's common stock. The sale, with an aggregate market value of approximately $135 million, is scheduled for 01/16/2024. The shares were originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, which had been in possession of the securities since 01/21/1937. Over the past three months, LILLY ENDOWMENT INC has sold a total of 225,000 shares of Eli Lilly, generating gross proceeds of nearly $142 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.